GB9108547D0 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
GB9108547D0
GB9108547D0 GB919108547A GB9108547A GB9108547D0 GB 9108547 D0 GB9108547 D0 GB 9108547D0 GB 919108547 A GB919108547 A GB 919108547A GB 9108547 A GB9108547 A GB 9108547A GB 9108547 D0 GB9108547 D0 GB 9108547D0
Authority
GB
United Kingdom
Prior art keywords
quinoline derivatives
quinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919108547A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GB919108547A priority Critical patent/GB9108547D0/en
Publication of GB9108547D0 publication Critical patent/GB9108547D0/en
Application status is Pending legal-status Critical

Links

GB919108547A 1991-04-22 1991-04-22 Quinoline derivatives Pending GB9108547D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB919108547A GB9108547D0 (en) 1991-04-22 1991-04-22 Quinoline derivatives

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB919108547A GB9108547D0 (en) 1991-04-22 1991-04-22 Quinoline derivatives
PCT/JP1992/000510 WO1992018483A1 (en) 1991-04-22 1992-04-21 Quinoline derivatives
EP19920908346 EP0639182A1 (en) 1991-04-22 1992-04-21 Quinoline derivatives
CA 2108971 CA2108971A1 (en) 1991-04-22 1992-04-21 Quinoline derivatives
MX9201823A MX9201823A (en) 1991-04-22 1992-04-21 Quinoline derivatives.
JP50778492A JPH06506925A (en) 1991-04-22 1992-04-21
HU9302983A HUT67349A (en) 1991-04-22 1992-04-21 Quinoline derivatives, pharmaceutical composition comprising them and their preparation
AU15487/92A AU656576B2 (en) 1991-04-22 1992-04-21 Quinoline derivatives

Publications (1)

Publication Number Publication Date
GB9108547D0 true GB9108547D0 (en) 1991-06-05

Family

ID=10693693

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919108547A Pending GB9108547D0 (en) 1991-04-22 1991-04-22 Quinoline derivatives

Country Status (8)

Country Link
EP (1) EP0639182A1 (en)
JP (1) JPH06506925A (en)
AU (1) AU656576B2 (en)
CA (1) CA2108971A1 (en)
GB (1) GB9108547D0 (en)
HU (1) HUT67349A (en)
MX (1) MX9201823A (en)
WO (1) WO1992018483A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311562D0 (en) * 1993-06-04 1993-07-21 Fujisawa Pharmaceutical Co Heterocyclic derivatives
GB9404378D0 (en) * 1994-03-07 1994-04-20 Fujisawa Pharmaceutical Co Quinoline derivatives
GB2290786A (en) * 1994-06-30 1996-01-10 Fujisawa Pharmaceutical Co Quinoline derivatives
US6165799A (en) * 1996-12-10 2000-12-26 Heska Corporation Detection of anti-Fc.sub.ε R autoantibodies in asthmatics
US6329525B1 (en) 1997-12-03 2001-12-11 Taisho Pharmaceutical Co., Ltd. 1,2-Dihydro-2-oxoquinoline derivatives
US6077851A (en) * 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
SE9801474D0 (en) * 1998-04-27 1998-04-27 Active Biotech Ab quinoline Derivatives
SE9802550D0 (en) * 1998-07-15 1998-07-15 Active Biotech Ab quinoline derivatives
SE9802549D0 (en) * 1998-07-15 1998-07-15 Active Biotech Ab quinoline derivatives
US6133285A (en) * 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
US6121287A (en) * 1998-07-15 2000-09-19 Active Biotech Ab Quinoline derivatives
JP2000044560A (en) * 1998-07-31 2000-02-15 Kyorin Pharmaceut Co Ltd Benzoquinolizine derivative and its production
JP2000044561A (en) * 1998-07-31 2000-02-15 Kyorin Pharmaceut Co Ltd Pyrroloquinoline derivative and its production
US6509352B1 (en) 1999-01-08 2003-01-21 Japan Tobacco Inc. 2-oxoquinoline compounds and medicinal uses thereof
US6395750B1 (en) 1999-10-25 2002-05-28 Active Biotech Ab Drugs for the treatment of malignant tumors
JP3950337B2 (en) * 1999-10-25 2007-08-01 アクティブ バイオテック エイビー Malignant tumor treatment
US6525049B2 (en) 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
EP1313734B1 (en) 2000-09-01 2009-11-11 Novartis Vaccines and Diagnostics, Inc. Aza heterocyclic derivatives and their therapeutic use
EP1650203B1 (en) 2000-09-11 2008-02-20 Novartis Vaccines and Diagnostics, Inc. Process of preparation of benzimidazol-2-yl quinolinone derivatives
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
US6822097B1 (en) 2002-02-07 2004-11-23 Amgen, Inc. Compounds and methods of uses
AUPS058102A0 (en) 2002-02-15 2002-03-14 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
EP2573079A3 (en) 2002-08-23 2015-03-11 Novartis AG Benzimidazole quinolinones and uses thereof
US7825132B2 (en) 2002-08-23 2010-11-02 Novartis Vaccines And Diagnostics, Inc. Inhibition of FGFR3 and treatment of multiple myeloma
NZ539425A (en) 2002-11-13 2007-11-30 Chiron Corp Methods of treating cancer and related methods
CA2520124A1 (en) 2003-03-28 2004-10-14 Chiron Corporation Use of benzazole compounds for immunopotentiation
CA2539162A1 (en) 2003-09-17 2005-03-31 Sumitomo Chemical Company, Limited Cinnamoyl derivatives and use thereof
US7989478B2 (en) 2003-09-17 2011-08-02 Sumitomo Chemical Company, Limited Cinnamoyl compound and use of the same
MXPA06004194A (en) 2003-11-07 2006-06-28 Chiron Corp Inhibition of fgfr3 and treatment of multiple myeloma.
RU2377988C2 (en) 2004-02-20 2010-01-10 Новартис Вэксинес Энд Дайэгностикс, Инк. Modulation of inflammatory and metastatic processes
NZ587548A (en) 2004-06-24 2012-05-25 Vertex Pharma Pharmaceutical uses of N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide
WO2006021340A1 (en) * 2004-08-23 2006-03-02 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
DK1845990T3 (en) 2005-01-27 2012-01-02 Novartis Vaccines & Diagnostic Treatment of metastatic tumors
AU2006219222A1 (en) 2006-03-02 2006-09-08 Sumitomo Chemical Company, Limited Use of cinnamoyl compound
ES2440799T3 (en) 2005-05-13 2014-01-30 Novartis Ag Methods to treat drug resistant cancer
MX2007014381A (en) 2005-05-17 2008-02-06 Novartis Ag Methods for synthesizing heterocyclic compounds.
WO2006127926A2 (en) 2005-05-23 2006-11-30 Novartis Ag Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
US20080293738A1 (en) 2005-11-29 2008-11-27 Novartis Ag Formulation of Quinolinones
EP1993360B1 (en) 2005-12-28 2017-02-08 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
SG10201504084QA (en) 2009-03-20 2015-06-29 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
CN102267984B (en) * 2010-06-04 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 4-hydroxyquinoline-3-amide derivatives, preparation method thereof and purposes thereof
RU2013120556A (en) * 2010-10-14 2014-11-20 Иммунар Аб 1,2-hydroxy-2-oxo-quinolin-3-carboxananides as ahr activators
CA2815935A1 (en) * 2010-11-28 2012-05-31 Mapi Pharma Ltd. Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
CN102146068A (en) * 2011-01-20 2011-08-10 南开大学 3-benzoyl-4-hydroxycoumarin derivatives and analogues thereof and application thereof in weeding aspect
AU2013226076B2 (en) 2012-02-27 2017-11-16 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof
JP2017530175A (en) 2014-10-07 2017-10-12 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Cocrystals of modulators of cystic fibrosis transmembrane conductance regulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473807A (en) * 1966-10-20 1969-06-15 Ciba Geigy A process for preparing new 4-hydroxy-quinolines
FR2443467B1 (en) * 1978-12-08 1981-08-14 Roussel Uclaf
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
FR2585356B1 (en) * 1985-07-25 1987-10-23 Roussel Uclaf Novel 4-substituted quinoline carboxylic oh acid 2 by two hydroxyl functions optionally etherified or esterified, their processes of preparation, the novel intermediates obtained, their application as medicines and compositions containing them
SE8902076D0 (en) * 1989-06-09 1989-06-09 Pharmacia Ab Derivatives of quinoline-3-carboxanilide

Also Published As

Publication number Publication date
MX9201823A (en) 1992-10-01
AU1548792A (en) 1992-11-17
JPH06506925A (en) 1994-08-04
WO1992018483A1 (en) 1992-10-29
AU656576B2 (en) 1995-02-09
EP0639182A1 (en) 1995-02-22
CA2108971A1 (en) 1992-10-23
HU9302983D0 (en) 1994-01-28
HUT67349A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
DE69224906D1 (en) Thermotropes flüssig-kristallines segment-blockcopolymer
AU643575B2 (en) Isoquinoline derivatives
DE69228192D1 (en) Wellpappe-palette
KR100246065B1 (en) Substituted 3-aminoquinuclidines
EG21209A (en) Indole derivatives
KR970011153B1 (en) Carbostyril derivatives
GB2256196B (en) Heterocyclic derivatives
GB2257579B (en) Pin-header
GR3021894T3 (en) Pallet-container
HK1000319A1 (en) 9-Amino-7-substituted-6-demethyl-6-deoxytetracyclines
ZA9203942B (en) Quinuclidine derivatives
AU656576B2 (en) Quinoline derivatives
HU9203552D0 (en) Substituted biphenyl-pyridones
IL102155D0 (en) Piperidine derivatives
GB9216272D0 (en) Substituted heterocycles
AP9500745A0 (en) Quinoline derivatives
GR3019778T3 (en) 5-heteroyl indole derivatives
NZ248946A (en) Piperidine derivatives
EP0516349A3 (en) 2-hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
GB9107813D0 (en) Tong
HU9302965D0 (en) Substituted benzyl amino-quinuclidine derivatives
HK1002706A1 (en) Carbostyril derivatives
CY1943A (en) Piperazinyl-and piperidinyl-cyclohexanols
PL174779B1 (en) Oxydiazine derivatives
HU9302554D0 (en) 3-aryl-pyrone derivatives